MedTrace Logo

Supplementation of Galatonol 300 mg / Striatin 30 mg in Postpartum Lactating Mothers

NCT06558071 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 160

Last updated 2026-02-17

No results posted yet for this study

Summary

This is a randomized, double-blind, and placebo-controlled study involving mothers as the participant and participant's babies evaluating the effect of a 15-day-supplementation with a product containing extracts derived from a combination of herbal plants (katuk \& torbangun leaves) and snakehead fish in stimulating breast milk production.

Conditions

  • Lactation Induced

Interventions

DRUG

Galatonol 300 mg/Striatin 30 mg

1 film-coated caplet of Herba Asimor, twice daily

DRUG

Placebo

1 film-coated caplet of placebo Herba Asimor, twice daily

Sponsors & Collaborators

  • Dexa Medica Group

    lead INDUSTRY

Principal Investigators

  • Fenny Yunita, MD, MSi, PhD · Faculty of Medicine, Universitas Tarumanagara

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-10-21
Primary Completion
2025-05-20
Completion
2025-05-27

Countries

  • Indonesia

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06558071 on ClinicalTrials.gov